日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CD73 expression as a resistance mechanism in advanced EGFR-mutated non-small cell lung cancer.

CD73 表达是晚期 EGFR 突变型非小细胞肺癌的一种耐药机制。

Eide Inger Johanne Zwicky, Dyrbekk Anne Pernille Harlem, Bisha Ina, Haberichter Thomas, Lakis Sotirios, Chan Jessica, Lewis Arthur, Martin Philip, Cooper Zachary A, Brustugun Odd Terje

IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors

IPH5201,一种抗CD39单克隆抗体,可作为单药疗法或与度伐利尤单抗联合用于治疗晚期实体瘤。

Powderly, John; Imbimbo, Martina; Italiano, Antoine; Martin-Romano, Patricia; McKean, Meredith; Macarulla, Teresa; Castañón Alvarez, Eduardo; Carneiro, Benedito A; Mager, Raymond; Barnhart, Vicky; Eck, Steven; Murtomaki, Elina; Loembé, Arsène-Bienvenu; He, Yun; Cooper, Zachary A; Tu, Eric; Fan, Chunling; Boyer Chamard, Agnes; Paturel, Carine; Fraenkel, Paula G; Hollebecque, Antoine

Quantifying CD73 expression after chemotherapy or chemoradiotherapy in esophageal squamous cell carcinoma.

定量分析食管鳞状细胞癌化疗或放化疗后 CD73 的表达

Cooper Zachary A, Wang Ying, Martin Philip L, Murayama Kosho, Kumar Rakesh, Kato Ken, Yamamoto Shun, Sekine Shigeki

A Phase Ib/II Randomized Clinical Trial of Oleclumab with or without Durvalumab plus Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

一项针对转移性胰腺导管腺癌患者的Ib/II期随机临床试验,评估奥莱克鲁单抗联合或不联合度伐利尤单抗及化疗的疗效

Coveler, Andrew L; Reilley, Matthew J; Zalupski, Mark; Macarulla, Teresa; Fountzilas, Christos; Ponz-Sarvisé, Mariano; Nagrial, Adnan; Uboha, Nataliya V; Frentzas, Sophia; Overman, Michael; Noonan, Anne; Messersmith, Wells A; Pavlakis, Nick; Mettu, Niharika B; Bisha, Ina; Wang, Ying; Smith, Paul; Murtomaki, Elina; Bielska, Agata A; Bragulat, Veronique; Cooper, Zachary A; Kumar, Rakesh; Spigel, David R

COLUMBIA-1: a randomised study of durvalumab plus oleclumab in combination with chemotherapy and bevacizumab in metastatic microsatellite-stable colorectal cancer

COLUMBIA-1:一项随机研究,评估度伐利尤单抗联合奥利克鲁单抗、化疗和贝伐珠单抗治疗转移性微卫星稳定型结直肠癌的疗效

Segal, Neil H; Tie, Jeanne; Kopetz, Scott; Ducreux, Michel; Chen, Eric; Dienstmann, Rodrigo; Hollebecque, Antoine; Reilley, Matthew J; Elez, Elena; Cosaert, Jan; Cain, Jason; Soo-Hoo, Yee; Hewson, Nicola; Cooper, Zachary A; Kumar, Rakesh; Tabernero, Josep

Exploring the Expression of Adenosine Pathway-Related Markers CD73 and CD39 in Colorectal and Pancreatic Carcinomas Characterized by Multiplex Immunofluorescence: A Pilot Study

利用多重免疫荧光技术探索结直肠癌和胰腺癌中腺苷通路相关标志物 CD73 和 CD39 的表达:一项初步研究

Lima, Cibelle Freitas; Tamegnon, Auriole; Rodriguez, Saxon; Maru, Dipen; Martin, Philip L; Cooper, Zachary A; Rodriguez-Canales, Jaime; Parra, Edwin Roger

Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors

腺样囊性癌的空间免疫分析揭示B7-H4是侵袭性肿瘤的治疗靶点

Sousa, Luana Guimaraes; McGrail, Daniel J; Lazar Neto, Felippe; Li, Kaiyi; Marques-Piubelli, Mario L; Ferri-Borgogno, Sammy; Dai, Hui; Mitani, Yoshitsugu; Spardy Burr, Nicole; Cooper, Zachary A; Kinneer, Krista; Cortez, Maria Angelica; Lin, Shiaw-Yih; Bell, Diana; El Naggar, Adel; Burks, Jared; Ferrarotto, Renata

First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors

首次人体研究评估了强效、选择性抗CD73单克隆抗体oleclumab单独使用或与durvalumab联合使用治疗晚期实体瘤患者的疗效。

Bendell, Johanna; LoRusso, Patricia; Overman, Michael; Noonan, Anne M; Kim, Dong-Wan; Strickler, John H; Kim, Sang-We; Clarke, Stephen; George, Thomas J; Grimison, Peter S; Barve, Minal; Amin, Manik; Desai, Jayesh; Wise-Draper, Trisha; Eck, Steven; Jiang, Yu; Khan, Anis A; Wu, Yuling; Martin, Philip; Cooper, Zachary A; Elgeioushi, Nairouz; Mueller, Nancy; Kumar, Rakesh; Patel, Sandip Pravin

The human tumor microbiome is composed of tumor type-specific intracellular bacteria

人类肿瘤微生物组由肿瘤类型特异性的细胞内细菌组成。

Nejman, Deborah; Livyatan, Ilana; Fuks, Garold; Gavert, Nancy; Zwang, Yaara; Geller, Leore T; Rotter-Maskowitz, Aviva; Weiser, Roi; Mallel, Giuseppe; Gigi, Elinor; Meltser, Arnon; Douglas, Gavin M; Kamer, Iris; Gopalakrishnan, Vancheswaran; Dadosh, Tali; Levin-Zaidman, Smadar; Avnet, Sofia; Atlan, Tehila; Cooper, Zachary A; Arora, Reetakshi; Cogdill, Alexandria P; Khan, Md Abdul Wadud; Ologun, Gabriel; Bussi, Yuval; Weinberger, Adina; Lotan-Pompan, Maya; Golani, Ofra; Perry, Gili; Rokah, Merav; Bahar-Shany, Keren; Rozeman, Elisa A; Blank, Christian U; Ronai, Anat; Shaoul, Ron; Amit, Amnon; Dorfman, Tatiana; Kremer, Ran; Cohen, Zvi R; Harnof, Sagi; Siegal, Tali; Yehuda-Shnaidman, Einav; Gal-Yam, Einav Nili; Shapira, Hagit; Baldini, Nicola; Langille, Morgan G I; Ben-Nun, Alon; Kaufman, Bella; Nissan, Aviram; Golan, Talia; Dadiani, Maya; Levanon, Keren; Bar, Jair; Yust-Katz, Shlomit; Barshack, Iris; Peeper, Daniel S; Raz, Dan J; Segal, Eran; Wargo, Jennifer A; Sandbank, Judith; Shental, Noam; Straussman, Ravid

Safety and clinical activity of intratumoral MEDI9197 alone and in combination with durvalumab and/or palliative radiation therapy in patients with advanced solid tumors

在晚期实体瘤患者中,单独使用瘤内注射 MEDI9197 以及联合使用度伐利尤单抗和/或姑息性放射疗法的安全性和临床活性

Siu, Lillian; Brody, Joshua; Gupta, Shilpa; Marabelle, Aurélien; Jimeno, Antonio; Munster, Pamela; Grilley-Olson, Juneko; Rook, Alain H; Hollebecque, Antoine; Wong, Rebecca K S; Welsh, James W; Wu, Yuling; Morehouse, Christopher; Hamid, Oday; Walcott, Farzana; Cooper, Zachary A; Kumar, Rakesh; Ferté, Charles; Hong, David S